No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Amgen Commences 2 Further BPCIA Denosumab Litigations – Against Alvotech/Dr Reddy’s & Amneal/mAbxience
On 6 November 2025, Amgen filed two separate BPCIA litigation suits in the US District Court for the District of New Jersey, against each of Dr Reddy’s/Alvotech and Amneal/mAbxience, asserting infringement of 31 US patents covering denosumab, pharmaceutical compositions of denosumab, methods of manufacturing therapeutic proteins like denosumab, and denosumab products.